FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula
,
where each R1 and R2 is independently selected from hydrogen, C1-C10alkyl, optionally substituted OH and OR3, where R3 represents C1-C10alkyl, or R1 and R2 together represent oxo or optionally C1-C10alkyl O-substituted oxime; W represents O, NR′ or CRaRb, where R′ represents either hydrogen, or C1-C10alkyl; X is either absent or represents CR4R5, where each Ra, Rb, R4 and R5 are independently selected from substituents, given for R1 and R2; Y and Z independently represent substituted or non-substituted nitrogen or carbon (substituents for which are given in i. 1 of the invention formula), or Y and Z together form optionally substituted pyrazolyl, imidazolyl, pyriminidyl, 1,2,4-triazolyl (substituents for which are given in i. 1 of the invention formula); R7a and R7b represent H; R6a and R6b represent H or R6a and R6b can be combined with formation of C3-C6cycloalkyl, optionally substituted with one or two substituents, selected from C1-C6alkyl and OH; Cy is selected from C1-6alkyl(C3-C8)cycloalkyl, phenyl, pyridinyl and thienyl; m equals 0 or 1; R8 represents F. the invention also relates to particular compounds, given in i. 1 of the invention formula, to pharmaceutical composition and method for treating malignant tumour.
EFFECT: novel methods for Akt inhibition.
19 cl, 1 dwg, 153 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH USE OF 2,4-PYRIMIDINEDIAMINE | 2013 |
|
RU2659777C2 |
2,4-PYRIMIDINDIAMINE COMPOUNDS HAVING EFFECT IN CASE OF AUTOIMMUNE DISORDERS | 2004 |
|
RU2356901C2 |
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE COMPOUND THEREOF | 2007 |
|
RU2434868C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY | 2015 |
|
RU2767460C2 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
Authors
Dates
2016-04-10—Published
2010-12-23—Filed